Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ccell.2020.09.019 http://scihub22266oqcxt.onion/10.1016/j.ccell.2020.09.019 33038939!7531591!33038939     free     free     free       Cancer+Cell 2020 ; 38 (5): 598-601 Nephropedia Template TP {{tp|p=33038939|t=2020. Cytokine Storms in Cancer and COVID-19 |pdf=|usr=}}{{33038939}} gab.com Text Cytokine Storms in Cancer and COVID-19 JO: Cancer Cell http://www.kidney.de/pget.php?&tw=1&pmid=33038939 #FOAvip During the COVID-19 pandemic, research on "cytokine storms" has been reinvigorated in the field of infectious disease, but it also has particular relevance to cancer research. Interleukin-6 (IL-6) has emerged as a key component of the immune response to SARS-CoV-2, such that the repurposing of anti-IL-6 therapeutics for COVID-19 is now a major line of investigation, with several ongoing clinical trials. We lay a framework for understanding the role of IL-6 in the context of cancer research and COVID-19 and suggest how lessons learned from cancer research may impact SARS-CoV-2 research and vice versa. Twit Text FOAVip Cytokine Storms in Cancer and COVID-19 ????Cancer Cell http://www.kidney.de/pget.php?&tw=1&pmid=33038939 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33038939 #FOAvip English Wikipedia <ref>{{Cite pmid|33038939}}</ref> Cytokine Storms in Cancer and COVID-19 #MMPMID33038939 Turnquist C; Ryan BM; Horikawa I; Harris BT; Harris CC Cancer Cell 2020[Nov]; 38 (5): 598-601 PMID33038939show ga During the COVID-19 pandemic, research on "cytokine storms" has been reinvigorated in the field of infectious disease, but it also has particular relevance to cancer research. Interleukin-6 (IL-6) has emerged as a key component of the immune response to SARS-CoV-2, such that the repurposing of anti-IL-6 therapeutics for COVID-19 is now a major line of investigation, with several ongoing clinical trials. We lay a framework for understanding the role of IL-6 in the context of cancer research and COVID-19 and suggest how lessons learned from cancer research may impact SARS-CoV-2 research and vice versa. |*Severity of Illness Index[MESH] |Betacoronavirus/*immunology[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/immunology/virology[MESH] |Cytokines/*blood/immunology[MESH] |Humans[MESH] |Inflammation/*etiology/pathology[MESH] |Neoplasms/blood/*immunology/virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/immunology/virology[MESH]Cytokine Storms in Cancer and COVID-19 (epmc).pdf DeepDyve Pubget Overpricing